Skip to main navigation
Skip to search
Skip to main content
Oregon Health & Science University Home
Search content at Oregon Health & Science University
Home
Profiles
Research units
Core Facilities
Publications
Neoadjuvant and adjuvant therapy for cholangiocarcinoma
Russell C. Kirks
,
Flavio G. Rocha
Research output
:
Chapter in Book/Report/Conference proceeding
›
Chapter
Overview
Fingerprint
Fingerprint
Dive into the research topics of 'Neoadjuvant and adjuvant therapy for cholangiocarcinoma'. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Adjuvant Therapy
100%
Neoadjuvant Therapy
100%
Cholangiocarcinoma
100%
Multidisciplinary Approach
25%
Malignancy
25%
Patient Selection
25%
Radiotherapy
25%
Systemic Therapy
25%
Prognostic Factors
25%
Targeted Therapy
25%
Metastatic Disease
25%
Curative Treatment
25%
Neoadjuvant
25%
Treatment Regimen
25%
Cytotoxic Chemotherapy
25%
High-risk Disease
25%
Liver Resection
25%
Biliary Tree
25%
Liver Parenchyma
25%
Upfront Resection
25%
Locoregional Therapy
25%
Multi-institutional Database
25%
Disease Absence
25%
Borderline Resectable
25%
Patient Fitness
25%
Disease Extent
25%
Selection Factors
25%
Adjuvant Setting
25%
Optimal Treatment Regimen
25%
Medicine and Dentistry
Neoadjuvant Therapy
100%
Adjuvant Therapy
100%
Cholangiocarcinoma
100%
Diseases
50%
Cancer
25%
Metastatic Carcinoma
25%
Prognostic Factor
25%
Patient Selection
25%
Targeted Therapy
25%
Cytotoxic Chemotherapy
25%
Hepatectomy
25%
Liver Parenchyma
25%
Radiation Therapy
25%